Genprex Inc. (NASDAQ: GNPX) Receives Orphan Drug Designation for Immunogene Therapy for Treatment of SCLC
NEW YORK, Sept. 21, 2023 (GLOBE NEWSWIRE) — via InvestorWire — Genprex Inc. (NASDAQ: GNPX)…
NEW YORK, Sept. 21, 2023 (GLOBE NEWSWIRE) — via InvestorWire — Genprex Inc. (NASDAQ: GNPX)…
NEW YORK, Sept. 21, 2023 (GLOBE NEWSWIRE) — via InvestorWire — Genprex Inc. (NASDAQ: GNPX)…
Contact Center Innovator Recognized as a Leader for Total Cost of Ownership (TCO) and Return…
IRVINE, Calif., Sept. 20, 2023 (GLOBE NEWSWIRE) — Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN) today…
BOSTON and ATLANTA, Sept. 20, 2023 (GLOBE NEWSWIRE) — Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (Inhibikase…
NEW YORK, Sept. 20, 2023 (GLOBE NEWSWIRE) — via IBN — Lucy Scientific Discovery (NASDAQ:…
Head to lead effort that empowers brands with high-performing, scalable, channel-agnostic AI content they can…
LONDON–(BUSINESS WIRE)–#Rocket– A university space programme from London are preparing to launch the most powerful British…
LOS ANGELES–(BUSINESS WIRE)–Afterparty, the platform empowering thousands of creators with the tools and technology for…
New MITRE-Harris Poll survey finds generational and gender differences in outlook for adoption BEDFORD, Mass….
LONDON–(BUSINESS WIRE)–#Rocket–A team of university students in London is preparing to launch the most powerful…
Rapidly expanding social platform drops waitlist, introduces AI to expand public conversation SAN FRANCISCO–(BUSINESS WIRE)–The…
SOUTH SAN FRANCISCO, Calif., Sept. 15, 2023 (GLOBE NEWSWIRE) — Pliant Therapeutics, Inc. (Nasdaq: PLRX),…
SOUTH SAN FRANCISCO, Calif., Sept. 15, 2023 (GLOBE NEWSWIRE) — Pliant Therapeutics, Inc. (Nasdaq: PLRX),…
Media Executive with 20+ Years of Broadcast Television Experience Will Oversee KTXL-TV and FOX40.com SACRAMENTO,…
AI, emergence of new drugs and the future of aging are topics for the 11th…
Combination with Desktop Metal to Create an Additive Manufacturing Powerhouse and Deliver Compelling Value for…
A new survey from Canva reveals how they’re embracing AI to elevate creativity and increase…
NEW YORK and VIENNA, Sept. 13, 2023 (GLOBE NEWSWIRE) — HOOKIPA Pharma Inc. (NASDAQ: HOOK,…
NEW YORK and VIENNA, Sept. 13, 2023 (GLOBE NEWSWIRE) — HOOKIPA Pharma Inc. (NASDAQ: HOOK,…